179 related articles for article (PubMed ID: 18339212)
1. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial.
Standl T; Lochbuehler H; Galli C; Reich A; Dietrich G; Hagemann H
Eur J Anaesthesiol; 2008 Jun; 25(6):437-45. PubMed ID: 18339212
[TBL] [Abstract][Full Text] [Related]
2. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.
Langeron O; Doelberg M; Ang ET; Bonnet F; Capdevila X; Coriat P
Anesth Analg; 2001 Apr; 92(4):855-62. PubMed ID: 11273914
[TBL] [Abstract][Full Text] [Related]
3. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
[TBL] [Abstract][Full Text] [Related]
4. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.
Gallandat Huet RC; Siemons AW; Baus D; van Rooyen-Butijn WT; Haagenaars JA; van Oeveren W; Bepperling F
Can J Anaesth; 2000 Dec; 47(12):1207-15. PubMed ID: 11132743
[TBL] [Abstract][Full Text] [Related]
5. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
Bagshaw SM; Chawla LS
Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial.
Rasmussen KC; Johansson PI; Højskov M; Kridina I; Kistorp T; Thind P; Nielsen HB; Ruhnau B; Pedersen T; Secher NH
Ann Surg; 2014 Feb; 259(2):249-54. PubMed ID: 24100337
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients.
Moggio RA; Rha CC; Somberg ED; Praeger PI; Pooley RW; Reed GE
Crit Care Med; 1983 Dec; 11(12):943-5. PubMed ID: 6196155
[TBL] [Abstract][Full Text] [Related]
9. Effects of colloid pre-loading on thromboelastography during elective intracranial tumor surgery in pediatric patients: hydroxyethyl starch 130/0.4 versus 5% human albumin.
Peng Y; Du J; Zhao X; Shi X; Wang Y
BMC Anesthesiol; 2017 Apr; 17(1):62. PubMed ID: 28449710
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis.
Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D
Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery.
Skhirtladze K; Base EM; Lassnigg A; Kaider A; Linke S; Dworschak M; Hiesmayr MJ
Br J Anaesth; 2014 Feb; 112(2):255-64. PubMed ID: 24169821
[TBL] [Abstract][Full Text] [Related]
12. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution.
Ickx BE; Bepperling F; Melot C; Schulman C; Van der Linden PJ
Br J Anaesth; 2003 Aug; 91(2):196-202. PubMed ID: 12878617
[TBL] [Abstract][Full Text] [Related]
13. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler Junior JO
Braz J Anesthesiol; 2013; 63(1):27-35. PubMed ID: 23438799
[TBL] [Abstract][Full Text] [Related]
14. Open randomized trial of the effects of 6% hydroxyethyl starch 130/0.4/9 and 5% albumin on safety profile, volume efficacy, and glycocalyx degradation in hepatic and pancreatic surgery.
Suzuki T; Koyama K
J Anesth; 2020 Dec; 34(6):912-923. PubMed ID: 32897437
[TBL] [Abstract][Full Text] [Related]
15. Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: A systematic review and stratified meta-analysis.
Rasmussen KC; Secher NH; Pedersen T
Medicine (Baltimore); 2016 Aug; 95(31):e4498. PubMed ID: 27495098
[TBL] [Abstract][Full Text] [Related]
16. Volume therapy in the critically ill: is there a difference?
Boldt J; Müller M; Mentges D; Papsdorf M; Hempelmann G
Intensive Care Med; 1998 Jan; 24(1):28-36. PubMed ID: 9503219
[TBL] [Abstract][Full Text] [Related]
17. Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study.
Buhre W; de Korte-de Boer D; de Abreu MG; Scheeren T; Gruenewald M; Hoeft A; Spahn DR; Zarbock A; Daamen S; Westphal M; Brauer U; Dehnhardt T; Schmier S; Baron JF; De Hert S; Gavranović Ž; Cholley B; Vymazal T; Szczeklik W; Bornemann-Cimenti H; Soro Domingo MB; Grintescu I; Jankovic R; Belda J
Trials; 2022 Feb; 23(1):168. PubMed ID: 35193648
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.
Altman C; Bernard B; Roulot D; Vitte RL; Ink O
Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):5-10. PubMed ID: 9512946
[TBL] [Abstract][Full Text] [Related]
19. Crystalloids vs. colloids: KO at the twelfth round?
Phillips DP; Kaynar AM; Kellum JA; Gomez H
Crit Care; 2013 May; 17(3):319. PubMed ID: 23731998
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery.
Kuitunen A; Suojaranta-Ylinen R; Kukkonen S; Niemi T
Scand J Surg; 2007; 96(1):72-8. PubMed ID: 17461317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
